Disseminated adenovirus infections in patients who received chemotherapy alone for lymphoma are extremely rare, however, should be included in differential diagnosis for those who received T cell suppressive agents. We report a fatal case of disseminated adenovirus disease in a patient who had received chemotherapy and presented with hypoxia

Guillain-Barre syndrome (GBS) is a rare autoimmune disease that often manifests as a post-viral complication. However, its association with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is unclear. We present a rare case of GBS secondary to COVID-19 infection complicated by rapidly progressive sensorimotor deterioration resistant to plasma exchange therapy.